Skip to main
AVNT

Avient Corp (AVNT) Stock Forecast & Price Target

Avient Corp (AVNT) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 0%
Buy 60%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Avient Corp has experienced a 5% increase in organic sales, indicating a robust demand for its product offerings in the Color, Additives and Inks, and Specialty Engineered Materials segments. Notably, the healthcare sector has shown impressive growth, with sales rising 14% year-over-year in the first half of 2025, sustained by double-digit growth for six consecutive quarters. Additionally, four out of nine end markets, which account for 40% of the company’s sales, are demonstrating growth this year, suggesting a diversified portfolio positioned favorably against ongoing market trends.

Bears say

Avient Corp has experienced a decline in organic sales, starting with a 2% decrease in the first quarter of 2024, followed by fluctuations in subsequent quarters that suggest inconsistent demand recovery. The company's performance in the chemicals sector has been adversely affected by weakening demand since mid-2025, raising concerns about potential volume risks in the second half of that year. Despite a favorable exchange rate environment from a declining U.S. dollar, the underlying negative trends in sales and demand do not provide a strong foundation for positive growth prospects.

Avient Corp (AVNT) has been analyzed by 5 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 60% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Avient Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Avient Corp (AVNT) Forecast

Analysts have given Avient Corp (AVNT) a Buy based on their latest research and market trends.

According to 5 analysts, Avient Corp (AVNT) has a Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $44.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $44.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Avient Corp (AVNT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.